Source: European Journal Pharmacology. Unidades: FCFRP, FORP
Subjects: ARTERIOSCLEROSE, ENZIMAS, RECEPTORES DE ANGIOTENSINA, FÁRMACOS
ABNT
PERNOMIAN, Larissa et al. MAS receptors mediate vasoprotective and atheroprotective effects of candesartan upon the recovery of vascular angiotensin-converting enzyme 2–angiotensin-(1-7)–MAS axis functionality. European Journal Pharmacology, v. 764, p. 173-188, 2015Tradução . . Disponível em: https://doi.org/10.1016/j.ejphar.2015.07.007. Acesso em: 09 nov. 2024.APA
Pernomian, L., Prado, A. F. do, Gomes, M. S., Pernomian, L., Silva, C. H. T. de P. da, Gerlach, R. F., & Oliveira, A. M. de. (2015). MAS receptors mediate vasoprotective and atheroprotective effects of candesartan upon the recovery of vascular angiotensin-converting enzyme 2–angiotensin-(1-7)–MAS axis functionality. European Journal Pharmacology, 764, 173-188. doi:10.1016/j.ejphar.2015.07.007NLM
Pernomian L, Prado AF do, Gomes MS, Pernomian L, Silva CHT de P da, Gerlach RF, Oliveira AM de. MAS receptors mediate vasoprotective and atheroprotective effects of candesartan upon the recovery of vascular angiotensin-converting enzyme 2–angiotensin-(1-7)–MAS axis functionality [Internet]. European Journal Pharmacology. 2015 ; 764 173-188.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1016/j.ejphar.2015.07.007Vancouver
Pernomian L, Prado AF do, Gomes MS, Pernomian L, Silva CHT de P da, Gerlach RF, Oliveira AM de. MAS receptors mediate vasoprotective and atheroprotective effects of candesartan upon the recovery of vascular angiotensin-converting enzyme 2–angiotensin-(1-7)–MAS axis functionality [Internet]. European Journal Pharmacology. 2015 ; 764 173-188.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1016/j.ejphar.2015.07.007